IGAR Breast System: MRI Breast Biopsy and Ablation

The CSii Image Guided Automatic Robot (IGAR) is designed for use in the early detection and treatment of breast cancer. With regulatory clearance the first IGAR robotic system will have four key product features; biopsy, ablation treatment, tele-operation, and seed placement/insertion.

The system is designed to offer one stop diagnosis and treatment for patients with high risk of breast cancer. The system has the ability to biopsy lesions, as well as ablate the lesion if clinically appropriate.

For those lesions or tumors that may require lumpectomy, image guided seed insertion/placement in the breast can also be done with IGAR, a method of marking the target to improve success rates, and avoid re-incision, which according to the literature ranges from 20-40%.

The Evolution of IGAR

The next version of the system will also be capable of performing sentinel node biopsy for staging of breast cancer. Currently, few surgeons in larger sites can perform a sentinel node biopsy due to the need for a highly skilled surgical team to conduct the procedure. Image guided accuracy to secure this tissue therefore has a significant advantage over standard manual procedures.

After establishing the IGAR system's capabilities in a solid organ such as the lung, we would progress to other diseases where image-guided accuracy is important; namely liver disease and kidney disease.  CSii will be able to further expand our future robotic offerings to improve patient care and surgeon practices via the creation of robotics in spinal surgery, ear/nose/throat (ENT) surgery, microsurgery and neurology.

IGAR - Breast:  From Concept to Completion in Four Years

Illustration gallery:

IGAR – Breast Prototype 1

IGAR – Breast Prototype, Imaging Research Centre

IGAR Prototype 2  & MRI – Imaging Research Centre

IGAR – Breast in MRI

IGAR Breast – Prototype for Clinical Trials